Edition:
India

Aurobindo Pharma Ltd (ARBN.NS)

ARBN.NS on National Stock Exchange of India

532.80INR
2:13pm IST
Change (% chg)

Rs7.25 (+1.38%)
Prev Close
Rs525.55
Open
Rs526.10
Day's High
Rs542.55
Day's Low
Rs525.00
Volume
2,934,020
Avg. Vol
2,235,867
52-wk High
Rs895.00
52-wk Low
Rs515.80

ARBN.NS

Chart for ARBN.NS

About

Aurobindo Pharma Limited is a pharmaceutical company. The Company is engaged in producing oral and injectable generic formulations and active pharmaceutical ingredients (APIs). Its product portfolio is spread over seven therapeutic/product areas, including antibiotics, anti-retrovirals, cardiovascular, central nervous system,... (more)

Overall

Beta: 1.08
Market Cap(Mil.): Rs365,971.41
Shares Outstanding(Mil.): 585.88
Dividend: 1.25
Yield (%): 0.52

Financials

  ARBN.NS Industry Sector
P/E (TTM): 15.65 29.41 30.38
EPS (TTM): 39.91 -- --
ROI: -- 13.85 13.36
ROE: -- 14.79 14.50

BUZZ-India's Aurobindo Pharma hits more than 2-mth low on US FDA observations

** Shares of Aurobindo Pharma Ltd fall as much as 5.01 pct to lowest since Feb. 16; top pct loser on NSE index

19 Apr 2017

BRIEF-Aurobindo Pharma says US FDA issued form 483 with 6 observations for unit-III

* Clarifies on news item "US FDA issues 5-6 'largely procedural' observations to Aurobindo Pharma's Unit-III"

19 Apr 2017

BRIEF-Aurobindo Pharma gets FDA nod for generic drug to treat HIV-1 infection

* Says Aurobindo Pharma receives USFDA approval for generic Epzicom tablets

30 Mar 2017

BRIEF-Aurobindo Pharma gets USFDA nod for Meropenem injection

* Meropenem injection is a generic equivalent of Astrazeneca Pharma's Merrem injection

28 Mar 2017

BRIEF-Aurobindo Pharma gets FDA nod for generic version of Reckitt Benckiser’s Mucinex DM tablets

* Says Aurobindo Pharma receives USFDA approval for guaifenesin and dextromethorphan hydrobromide

20 Mar 2017

Aurobindo plans second U.S. plant as Trump calls for local production

MUMBAI Indian drugmaker Aurobindo Pharma plans to set up a factory in the United States for injectable products, it said on Friday, days after U.S. President Donald Trump called on pharmaceutical companies to make more drugs locally.

10 Feb 2017

Aurobindo plans second U.S. plant as Trump calls for local production

MUMBAI Indian drugmaker Aurobindo Pharma plans to set up a factory in the United States for injectable products, it said on Friday, days after U.S. President Donald Trump called on pharmaceutical companies to make more drugs locally.

10 Feb 2017

India's Aurobindo eyes U.S. plant amid Trump push on jobs

MUMBAI, Feb 10 Indian drugmaker Aurobindo Pharma said on Friday it was looking to set up a manufacturing facility for injectable products in the United States, days after President Donald Trump called on pharmaceutical companies to make more drugs locally.

10 Feb 2017

BUZZ-India's Aurobindo Pharma up; U.S. FDA okays firm's generic treatment for seizures

** Shares of Aurobindo Pharma up as much as 4.32 pct, its highest since Dec 12

09 Jan 2017

India's Aurobindo shares hit nine-month low on US price-fixing lawsuit

MUMBAI Indian drugmaker Aurobindo Pharma Ltd's shares hit their lowest in more than nine months on Friday after the company was named in a lawsuit alleging it colluded with other drugmakers to fix prices of two commonly used drugs in the United States.

16 Dec 2016

More From Around the Web

Earnings vs. Estimates